Core Laboratories N.V. (CLB) financial statements and ratios from SEC XBRL: revenue $0.5B (TTM), net margin 5.6%, revenue growth -4.3% YoY, P/E 23.5. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (latest FY) | $526.52M |
| Revenue (TTM) | $0.5B |
| Net Margin | 5.6% |
| Operating Margin (TTM) | 9.2% |
| Net Debt / EBITDA | 1.5 |
| Revenue Growth (YoY) | -4.3% |
| EPS Growth (YoY) | -43.5% |
| FCF Growth (YoY) | -70.1% |
| P/E Ratio | 23.5 |
| EV / EBITDA | 10.6 |
| Price / Book | 2.05 |
| Price / Sales | 1.10 |
| FCF Yield | 4.5% |
| Altman Z-Score | 2.96 (grey) |
| Piotroski F-Score | 7/9 |
| Piotroski checks passed | 7 of 9 |
| Industry P/E (Petroleum & Natural Gas) | 15.4 |
| Sector P/E (Energy) | 16.1 |
CLB overview · CLB earnings · CLB KPIs · CLB documents · CLB ownership · CLB peers
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.